Could a brain injection slow Parkinson's? new trial begins
NCT ID NCT07157345
First seen Nov 01, 2025 · Last updated May 18, 2026 · Updated 23 times
Summary
This early-stage study tests a new treatment called PDR-001 for people with Parkinson's disease. The treatment is a peptide delivered directly into the brain to clear a harmful protein called alpha-synuclein, which is linked to Parkinson's. The main goal is to check safety in 12 participants, but researchers will also look for signs that it might slow the disease. This is not a cure, as ongoing medication is still needed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE (PD) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ruijin hospital
RECRUITINGShanghai, Shanghai Municipality, 200000, China
Conditions
Explore the condition pages connected to this study.